• linkedin
  • Increase Font
  • Sharebar

    Treating ROP: Laser associated with high success rate for retinopathy of prematurity

    Laser photocoagulation is a time-tested, well-defined, and effective treatment for retinopathy of prematurity (ROP) with requirements for follow-up that are much more manageable compared with anti-vascular endothelial growth factor (anti-VEGF) therapy, argued David K. Wallace, MD, MPH.

    Read the other side of the debate: Treating ROP: Substantial benefits make anti-VEGF preferred for Zone I disease

    Dr. Wallace outlined the reasons why a physician might choose laser over anti-VEGF injections for treating ROP.

    “There are situations where anti-VEGF injections may be better than laser treatment, such as in eyes with Zone I disease,” said Dr. Wallace, professor of ophthalmology and pediatrics, Duke University, Durham, NC.  “In addition, we might use both treatments in eyes with Zone I disease, adding laser after anti-VEGF therapy if vascularization stalls and worrisome signs develop. However, there are cases where laser may be a better choice, and there is still a lot we need to know about anti-VEGF therapy for ROP.”

    Presenting a “top-10 list” of reasons to consider laser for ROP rather than anti-VEGF therapy, Dr. Wallace said the absence of systemic side effects with laser versus the yet-to-be-defined systemic safety of anti-VEGF therapy represents the most compelling argument.

    “We know that anti-VEGF drugs enter the blood and that serum VEGF levels are reduced after intravitreal anti-VEGF injection,” Dr. Wallace explained. “We don’t know how reductions in circulating VEGF affect developing organs that rely on VEGF, but a recent study analyzing data from the Canadian registry of premature infants found significantly worse motor development in preterm babies treated with bevacizumab (Avastin, Genentech) compared with those treated with laser [Pediatrics. 2016 Apr;137(4)].”

    Follow-up favors laser

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow

    var script= ' ';